Literature DB >> 6299409

Naloxone and self-mutilation.

J S Richardson, W A Zaleski.   

Abstract

A 15-year-old male with a long history of self-mutilation resembling the Lesch-Nyhan syndrome, but with normal uric acid levels, was treated with naloxone. Pain-inducing behavior decreased in the evenings following infusion of the drug, and was markedly reduced for 2 days following the treatment period. Though not recommended as therapy, the observations suggest that naloxone may play a role in the regulation of endorphin/enkephalin neural systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299409     DOI: 10.1016/0378-1097(83)90142-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.

Authors:  R Knabe; P Schulz; J Richard
Journal:  J Autism Dev Disord       Date:  1990-12

2.  Brief report: plasma beta-endorphin and cortisol levels in autistic patients.

Authors:  C A Sandman; J L Barron; A Chicz-DeMet; E M DeMet
Journal:  J Autism Dev Disord       Date:  1991-03

3.  Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.

Authors:  J Panksepp; P Lensing
Journal:  J Autism Dev Disord       Date:  1991-06

Review 4.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

Review 5.  Physical and social pains in borderline disorder and neuroanatomical correlates: a systematic review.

Authors:  Déborah Ducasse; Philippe Courtet; Emilie Olié
Journal:  Curr Psychiatry Rep       Date:  2014-05       Impact factor: 5.285

6.  Clinical Features and Drug Treatment of Psychodermatological Disorders.

Authors:  M Van Moffaert
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

7.  Brain opioids and autism: an updated analysis of possible linkages.

Authors:  T L Sahley; J Panksepp
Journal:  J Autism Dev Disord       Date:  1987-06

8.  A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Authors:  A S Walters; R P Barrett; C Feinstein; A Mercurio; W T Hole
Journal:  J Autism Dev Disord       Date:  1990-06

9.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.